Asarfi Hospital Board of Directors

Get the latest insights into the leadership at Asarfi Hospital. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Sudipa SinghCompany Secretary & Compliance Officer
Udai Pratap SinghManaging Director
Madhuri SinghExecutive Director
Gopal SinghExecutive Director
Sukanti Kumar DasNon Executive Director
Amit Kumar BarnwalNon Executive Independent Director
Rajkumari SharmaNon Executive Independent Director

Asarfi Hospital Share price

ASARFI

208

14.85 (-6.66%)
Last updated on 24 Apr, 2026 | 15:29 IST
Today's High

224.90

Today's Low

206.25

52 Week Low

85.00

52 Week High

236.40

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Asarfi Hospital FAQs

The board at Asarfi Hospital consists of experienced professionals, including Sudipa Singh, Udai Pratap Singh, and others, overseeing the company’s strategic and corporate governance.

Directors at Asarfi Hospital are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Sudipa Singh is the current chairman at Asarfi Hospital.

Executive directors at Asarfi Hospital are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Asarfi Hospital adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Asarfi Hospital, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost